» Articles » PMID: 6653884

Expression of Hepatitis B Surface Antigen in Yeast

Overview
Journal Dev Biol Stand
Publisher Karger
Date 1983 Jan 1
PMID 6653884
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The genomes of HBV viruses of two different serotypes were cloned in E. coli. Sequences coding for the major polypeptides of surface antigen (HBsAg) were fused with the 5' end of a cloned yeast arg3 gene. When introduced into yeast, on a suitable vector, the hybrid gene directed the synthesis of a fusion protein. Crude extracts of such strains were shown to contain HBsAg like material having physical properties characteristic of the antigen isolated from the plasma of chronic human carriers, as judged by isopycnic and rate zonal centrifugation. Furthermore, these extracts readily elicit specific anti-HBsAg antibodies in rabbits. Further manipulations of the 5' part of the arg3 gene resulted in the introduction of a unique restriction site located in the 5' non translated leader sequence. The resulting vector was used to construct a recombinant plasmid directing the synthesis of the mature (226 amino acids) HBsAg polypeptide.

Citing Articles

Exploring the optimal vaccination strategy against hepatitis B virus in childhood (Review).

Kramvis A, Mammas I, Spandidos D Biomed Rep. 2023; 19(1):48.

PMID: 37383679 PMC: 10293880. DOI: 10.3892/br.2023.1631.


Analysis of the Physicochemical Properties, Replication and Pathophysiology of a Massively Glycosylated Hepatitis B Virus HBsAg Escape Mutant.

Hossain M, Suwanmanee Y, Du K, Ueda K Viruses. 2021; 13(11).

PMID: 34835134 PMC: 8622389. DOI: 10.3390/v13112328.


Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.

Moradi Vahdat M, Hemmati F, Ghorbani A, Rutkowska D, Afsharifar A, Eskandari M Biotechnol Rep (Amst). 2021; 29:e00605.

PMID: 33732633 PMC: 7937989. DOI: 10.1016/j.btre.2021.e00605.


Elicitation of integrated immunity in mice by a novel pneumococcal polysaccharide vaccine conjugated with HBV surface antigen.

Qian W, Huang Z, Chen Y, Yang J, Wang L, Wu K Sci Rep. 2020; 10(1):6470.

PMID: 32286332 PMC: 7156719. DOI: 10.1038/s41598-020-62185-7.


Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Ho J, Jeevan-Raj B, Netter H Viruses. 2020; 12(2).

PMID: 31973017 PMC: 7077199. DOI: 10.3390/v12020126.